Keurig Dr Pepper (KDP) Q1 2025 earnings summary

Executive summary

• Q1 2025 delivered strong results with net sales up 4.8% to $3.64 billion and GAAP net income up 13.9% to $517 million, driven by robust U.S. Refreshment Beverages and operational discipline, while U.S. Coffee and International segments faced headwinds.

• Adjusted diluted EPS rose 10.5% to $0.42, aided by operating income growth and a gain from the sale of the Vita Coco investment.

• Market share gains were achieved across core brands like Dr Pepper, Canada Dry, and new launches such as Dr Pepper Blackberry and Electrolit, with energy brands GHOST and C4 contributing significantly.

• Strategic initiatives advanced, including the acquisition of a controlling interest in GHOST, monetization of the Vita Coco stake, and the appointment of two new independent directors.

• JAB reduced its stake below 10% and its board members resigned.

Financial highlights

• Net sales increased 4.8% year-over-year to $3.64 billion; constant currency net sales up 6.4%.

• Adjusted operating income rose 3.9% to $847 million (23.3% of net sales); GAAP operating income up 4.7% to $801 million.

• Adjusted EPS increased 10.5% to $0.42; GAAP net income up 13.9% to $517 million.

• Gross margin contracted 130–170 basis points year-over-year due to inflation and competition.

• Free cash flow was $102 million, impacted by a one-time $225 million GHOST distribution transition payment.

Outlook and guidance

• Full-year 2025 guidance reaffirmed: mid-single-digit net sales growth (constant currency) and high single-digit adjusted EPS growth.

• FX expected to be a 1 percentage point headwind; interest expense projected at $680–$700 million, tax rate at 22–23%.

• Tariff impacts are manageable with mitigation steps in place, including cost savings, pricing, and sourcing flexibility.

• Management expects sufficient liquidity for the next twelve months and beyond, supported by strong operating cash flows and available credit.

• U.S. coffee segment expected to remain subdued in 2025, with improvement anticipated in the second half as pricing normalizes.